Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma Guide

Delpharm Consultants Pty Limited

Delpharm Consultants is one of Australia's leading independent consultancies focusing on pharmaceutical development and related regulatory issues.

Since 1994 we have been providing high quality consultancy and impartial advice to members of the pharmaceutical and biotechnology industries, including advice in areas such as:


Clinical Trial Design and Management;
Regulatory Management Services;
Commercialisation;
GCP Compliance Audits; and
Data Reduction and Final Reports.

Our experienced consultants have held senior positions in the pharmaceutical industry and have considerable expertise in the areas of contract and academic research.

Address: Suites 211 & 212, 5 Alexander St
State: NSW
Suburb: Crows Nest
Postcode: 2065

Phone: (02) 9966-8622
Fax: (02) 9966-9244
Email: delphar@bigpond.net.au
Web address: www.delpharm.com.au

Special Report
PBAC reveals giant November agenda
As anticipated, the November 2016 PBAC agenda is huge with 36 major submissions and 26 minor but comparatively few on the parallel processing track.
Approvals Action
Apotex sets sights on $146m Novartis drug
Apotex has registered two new brands for one of Novartis' biggest selling products as patent expiry looms.
PBAC Outcomes
PBAC in major denial mode
The PBAC either rejected or deferred 16 major submissions and resubmissions at its July meeting with another three parallel submissions held off because TGA data was insufficient; only seven majors were recommended for listing.
Pipeline Monitor
Gilead wins speedy review for HIV hope
Gilead has filed its latest drug combo in the US with hopes of maintaining HIV sales as hep C blockbusters fall back.